MedX, a Tokyo-based healthcare hrtech startup, was selected for the Tokyo Metropolitan Government's ASAC Seed 23rd cohort. It was one of 12 startups chosen from a combined pool of 125 applications. The company completed the ASAC Pre-Seed 3rd program in July 2026.
Program details
The Seed program runs from November 10 for about five months. It ends with a demo day planned for late March 2027. The program is free and includes mentoring from venture capitalists.
Company background
MedX was founded on April 14, 2025, and is led by CEO Ryota Migitaka. It builds an AI- and SNS-based self-running recruitment model for hospitals. The startup also supports nurses who want to return to hospital work in Tokyo.
Nurse shortage context
Tokyo's regular nurse turnover rate was 15.5% in 2022, above the 11.8% national average. Around 700,000 licensed nurses nationwide are not working in nursing. MedX aims to connect these workers with medical institutions.
During the Seed program, MedX plans to build its SNS recruitment service and a return-to-work program. It will also prepare for fundraising and business partnerships. The company aims to expand its Tokyo model to hospitals across Japan.